|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/20 Aikido Pharma Inc. 8-K:8,9 3/27/20 2:33K Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 14K 2: EX-99.1 Press Release, Dated March 27, 2020 HTML 8K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
| FORM 8-K |
| CURRENT REPORT |
|
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
| Date of Report (Date of earliest event reported): March 27, 2020 |
| AIKIDO PHARMA INC. |
| (Exact name of registrant as specified in its charter) |
| Delaware | 000-05576 | 52-0849320 |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| One Rockefeller Plaza, 11th Floor, New York, NY | 10020 |
| (Address of principal executive offices) | (Zip Code) |
| Registrant’s telephone number, including area code: (703) 992-9325 | |
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | |
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.0001 par value | AIKI | The Nasdaq Capital Market |
C:
| Item 8.01 | Other Events. |
On March 27, 2020, AIkido Pharma Inc., a Delaware corporation (the “Company”), issued a press release (the “Press Release”) announcing that the record date and distribution date to the Company’s stockholders of shares of Hoth Therapeutics, Inc. (“Hoth”) will be deferred because of the requirement that the shares be registered prior to distribution. AIkido will provide a record date and distribution date for the distribution of the shares promptly once the registration statement is declared effective and will issue an update to stockholders in two weeks on the status of this matter.
A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated by reference in this Current Report.
Item 9.01. Financial Statements and Exhibits
d) Exhibits.
The exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K.
| Exhibit No. | Description | |
| 99.1 | Press Release, dated March 27, 2020 |
C:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AIKIDO PHARMA INC. | ||
| By: | /s/ Anthony Hayes | |
|
Name: Title: |
Anthony Hayes Chief Executive Officer | |
Dated: March 27, 2020
C:
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 3/30/20 | None on these Dates | ||
| Filed on / For Period end: | 3/27/20 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/01/22 Dominari Holdings Inc. 424B5 1:743K EdgarAgents LLC/FA 3/01/22 Dominari Holdings Inc. 424B5 1:786K EdgarAgents LLC/FA 2/18/21 Dominari Holdings Inc. 424B5 1:859K EdgarAgents LLC/FA 2/16/21 Dominari Holdings Inc. 424B5 1:787K EdgarAgents LLC/FA 8/26/20 Dominari Holdings Inc. S-1/A 3:956K EdgarAgents LLC/FA 8/17/20 Dominari Holdings Inc. S-1 2:844K EdgarAgents LLC/FA |